Effect of urotensin II on skin microvessel tone in diabetic patients without heart failure or essential hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 10, 2008, Pages 1147-1150

  Zomer, E ^a   De Ridder, I ^a   Kompa, A ^a,c   Komesaroff, P ^b   Gilbert, R E ^d   Krum, H ^a  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Diabetes mellitus; Endothelium; Ions; Peptides; Urotensin II; Vasculature

Indexed keywords

ACETYLCHOLINE; NITROPRUSSIDE SODIUM; UROTENSIN II;

ADULT; ARTICLE; BLOOD FLOW; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROCIRCULATION; MICROVASCULATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; VASOCONSTRICTION; VASODILATATION;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; IONTOPHORESIS; MALE; MICROVESSELS; MIDDLE AGED; REGIONAL BLOOD FLOW; SKIN; UROTENSINS; VASOCONSTRICTION; VASODILATION;

EID: 50649104183     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04960.x     Document Type: Article

References (11)

1. Krum H, Kompa A, Hannah R, Thomas W. Emerging role of the urotensin II system in cardiovascular disease. Heart Drug 2003 3 : 153 8.
2. Matsushita M, Shichiri M, Fukai N et al. Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1. Endocrinology 2003 144 : 1825 31.
3. Ames RS, Sarau HM, Chambers JK et al. Human urotesin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 1999 401 : 282 6.
4. Langham RG, Kelly DJ, Gow RM et al. Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy. Am. J. Kidney Dis. 2004 44 : 826 31.
5. Totsune K, Takahashi K, Arihara Z et al. Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: Association with progression of diabetic nephropathy. Peptides 2004 25 : 1809 14.
6. Russel FD, Molenaar P. Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart. Cardiovasc. Res. 2004 63 : 673 81.
7. Sondermeijer B, Kompa A, Komesaroff P, Krum H. Effect of exogenous urotensin II on vascular tone in skin microcirculation of patients with essential hypertension. Am. J. Hypertens. 2005 18 : 1195 9.
8. Lim M, Honisett S, Sparkes CD, Komesaroff P, Kompa A, Krum H. Differential effects of urotensin II on vascular tone in normal subjects and patients with chronic heart failure. Circulation 2004 109 : 1212 14.
9. Hillier C, Berry C, Petrie MC et al. Effects of urotensin II in human arteries and veins of varying caliber. Circulation 2001 103 : 1378 81.
10. Bohm F, Pernow J. Urotensin II evokes potent vasoconstriction in humans in vivo. Br. J. Pharmacol. 2002 135 : 25 7.
11. Wilkinson IB, Affolter JT, de Haas SL et al. High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man. Cardiovasc. Res. 2002 53 : 341 7.